Regenerative Medicine Foundation
  • Leadership
  • What We Do
    • Policy
    • Advocacy
    • Education & Outreach
  • Events
    • World Stem Cell Summit
    • Regenerative Medicine Essentials
    • The “Art of Science” Inspires Students
    • Exploring Public Policy: Regenerative Medicine and Cell Therapies
    • Congressional Briefings
    • Regenerative Medicine and Stem Cell Action Awards
    • World Stem Cell Summit – CHINA
  • Membership/Register
    • Membership – Register for WSCS and RME Course
    • Donate
    • Amazon SMILE
  • News
    • News
    • Portraits of Hope
    • Video
    • Video Chats
  • Contact
Select Page

Longeveron Aging Frailty Phase 2b Trial

by Kevin McMahon | Jan 21, 2018 | News & Opinions, Science

Longeveron is currently enrolling subjects in its Phase 2b multi-center clinical trial designed to test the safety and efficacy of Longeveron Mesenchymal Stem Cells (LMSCs) for the treatment of subjects with clinically diagnosed with Aging Frailty. This is the only...

Aging Frailty with Influenza Vaccine Trial announced by Longeveron

by Kevin McMahon | Jan 21, 2018 | News & Opinions, Science

America is facing one of the worst influenza seasons in recent history. The influenza virus is one of the top ten causes of death in elderly people. Longeveron is conducting a multi-center, randomized, placebo controlled trial using its Longeveron Mesenchymal Stem...

Recent Posts

  • The Tennessee Institute of Regenerative Medicine Gains International Reach With New Partnership
  • National Survey IDs Gaps and Opportunities for Regenerative Medicine Workforce
  • The Dawn Of A New Era Of Regenerative Medicine: Tissue Engineering Comes Of Age
  • The Memphis Institute of Regenerative Medicine Rebrands To Reflect Statewide Reach
  • ISS National Lab to Host Session at World Stem Cell Summit on Regenerative Medicine in Low Earth Orbit
Tweets about @WSCSummit
CC Regenerative Medicine Foundation